Optimal Use of Echocardiography in Management of Thrombosis After Anterior Myocardial Infarction.
Andrea BarbieriAlessandro MalagoliFrancesca BursiAndrea FaggianoGiuseppe BorianiPompilio FaggianoPublished in: Echocardiography (Mount Kisco, N.Y.) (2020)
Despite advancement in therapy and management, left ventricular thrombus (LVT) after anterior myocardial infarction (MI) is sporadically encountered and remains associated with a very high risk of major cardiovascular events and mortality. Cardiac magnetic resonance (CMR) is considered the gold standard technique for LVT detection, but it is a time-consuming and expensive test not available in all centers, especially when repeated examinations are necessary. Transthoracic echocardiography represents a useful tool to screen for LVT and to identify predictors of high risk of developing LVT. The advances in ultrasound technology and the use of contrast agents may potentially help clinicians to identify LVT and the use of sequential echocardiography for each patient with acute MI complicated by LVT may provide an opportunity to quantify regression and its correlation with outcomes to tailor the management of these patients. Hence, this narrative review focuses on the added value of echocardiographic-guided LVT management in patients with recent anterior MI to reduce mortality and morbidity excess related to LVT based on current evidence.
Keyphrases
- left ventricular
- cardiovascular events
- magnetic resonance
- heart failure
- hypertrophic cardiomyopathy
- pulmonary hypertension
- mitral valve
- acute myocardial infarction
- left atrial
- coronary artery disease
- computed tomography
- end stage renal disease
- magnetic resonance imaging
- high throughput
- aortic stenosis
- stem cells
- case report
- adipose tissue
- palliative care
- intensive care unit
- type diabetes
- risk factors
- prognostic factors
- bone marrow
- respiratory failure
- patient reported outcomes
- single cell
- label free
- silver nanoparticles